Yes, testosterone replacement therapy can cause flushing, though it is generally considered a minor and uncommon side effect.
Flushing is recognized as a known adverse effect of testosterone therapy, categorized alongside acne, oily skin, and increased body hair as a "minor inconvenience" rather than a serious concern 1.
Clinical Significance
The evidence from authoritative guidelines indicates that flushing occurs with testosterone replacement therapy but is:
- Not considered clinically significant in terms of morbidity or mortality
- Classified as a minor inconvenience rather than a serious adverse event
- Not typically a reason to discontinue therapy or require specific monitoring
The New England Journal of Medicine guidelines on testosterone replacement therapy explicitly list flushing among the miscellaneous effects but do not recommend any specific monitoring or management for this symptom 1.
Important Clinical Context
Paradoxical Presentation
Interestingly, flushing can also be a symptom of testosterone deficiency itself, particularly in men with secondary hypogonadism. Research has documented a "pseudocarcinoid syndrome" where men with hypogonadism experience flushing episodes that actually resolve with testosterone treatment 2. This creates a diagnostic challenge where flushing could represent either:
- A side effect of testosterone therapy
- A symptom of untreated hypogonadism that improves with treatment
Prevalence in Aging Men
Hot flushes occur in approximately 33% of older men not receiving testosterone therapy, with 4.3% experiencing them at least weekly 3. This baseline prevalence makes it difficult to attribute flushing solely to testosterone treatment without careful clinical assessment.
Formulation-Specific Considerations
While the guidelines do not specify differential rates of flushing by formulation, they do note that:
- Transdermal preparations cause high rates of local skin reactions (erythema and pruritus in up to 66% with patches, 5% with gels) 1
- Intramuscular injections can cause local erythema at injection sites 1
- These local reactions are distinct from systemic flushing
Clinical Management Approach
If a patient develops flushing on testosterone therapy:
- Verify the symptom is new - Ask whether flushing was present before starting therapy, as it may have been a symptom of hypogonadism itself
- Assess severity - Determine if it affects quality of life or is merely bothersome
- Continue therapy - Flushing alone is not an indication to stop treatment given its classification as a minor inconvenience
- Monitor for serious adverse effects - Focus monitoring on hematocrit, PSA, cardiovascular symptoms, and sleep apnea rather than flushing 1
Bottom Line
Flushing can occur with testosterone therapy but does not impact mortality, morbidity, or significantly affect quality of life in most patients. It should not alter treatment decisions unless it becomes severely bothersome to the patient. The more critical focus should remain on monitoring for serious adverse effects like erythrocytosis, cardiovascular events, and prostate complications.